Welcome to LookChem.com Sign In|Join Free
  • or
Propanedioyl dichloride, phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

37818-48-7

Post Buying Request

37818-48-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

37818-48-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 37818-48-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,8,1 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 37818-48:
(7*3)+(6*7)+(5*8)+(4*1)+(3*8)+(2*4)+(1*8)=147
147 % 10 = 7
So 37818-48-7 is a valid CAS Registry Number.

37818-48-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-phenylpropanedioyl dichloride

1.2 Other means of identification

Product number -
Other names Phenylmalonsaeuredichlorid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:37818-48-7 SDS

37818-48-7Relevant academic research and scientific papers

Carboxylate-Driven Supramolecular Assemblies of Protonated meso-Aryl-Substituted Dipyrrolylpyrazoles

Maeda, Hiromitsu,Chigusa, Kengo,Yamakado, Ryohei,Sakurai, Tsuneaki,Seki, Shu

, p. 9520 - 9527 (2015)

Dipyrrolylpyrazole (dpp) derivatives possessing an aryl ring at the pyrazole 4-position were synthesized. Upon protonation, modified dpp derivatives formed a variety of assembled structures through complexation with carboxylates, as observed by single-cry

Mesoionic pyrido[1,2-a]pyrimidinones: Discovery of dicloromezotiaz as a lepidoptera insecticide acting on nicotinic acetylcholine receptors1,2

Zhang, Wenming,Holyoke, Caleb W.,Barry, James,Cordova, Daniel,Leighty, Robert M.,Tong, My-Hanh T.,Hughes, Kenneth A.,Lahm, George P.,Pahutski, Thomas F.,Xu, Ming,Briddell, Twyla A.,McCann, Stephen F.,Henry, Yewande T.,Chen, Yuzhong

, p. 911 - 917 (2017/02/10)

A novel class of mesoionic pyrido[1,2-a]pyrimidinones has been discovered with exceptional insecticidal activity controlling a number of insect species. In this communication, we report the part of the optimization program that led to the identification o

All-Carbon [3+3] Oxidative Annulations of 1,3-Enynes by Rhodium(III)-Catalyzed C-H Functionalization and 1,4-Migration

Burns, David J.,Best, Daniel,Wieczysty, Martin D.,Lam, Hon Wai

supporting information, p. 9958 - 9962 (2015/08/19)

1,3-Enynes containing allylic hydrogens cis to the alkyne function as three-carbon components in rhodium(III)-catalyzed, all-carbon [3+3] oxidative annulations to produce spirodialins. The proposed mechanism of these reactions involves the alkenyl-to-ally

A stable Janus bis(maloNHC) and its zwitterionic coinage metal complexes

Tapu, Daniela,McCarty, Zachary,McMillen, Colin

supporting information, p. 4725 - 4728 (2014/05/06)

The first stable dianionic Janus-type bis(maloNHC) was isolated and characterized. Details on the chemistry of this biscarbene with respect to its ability to support catalytically relevant metal complexes are provided. The molecular structures of two dinu

HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt

-

Paragraph 0410; 0411, (2014/05/07)

The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

Preparation of arylpropynamides and their reaction with malonyl acid derivatives

Petina, Olgaa. A.,Yakovlev, Igorp. P.,Geffken, Detlef

, p. 803 - 809 (2013/04/10)

Synthesis of arylpropynamides and their reactions with different malonic acid derivatives is described. Treatment of arylpropynamides with unsubstituted malonyl chloride furnished N-(3-arylprop-2-ynoyl)-6-chloro-4-hydroxy-2-oxo-2H- pyran-3-carboxamides; m

Total synthesis of monocyclic pyrimidinium betaines with fatty alkyl chains

Malki, Fatiha,Touati, Abdelkader,Rahal, Said,Moulay, Saad

experimental part, p. 961 - 967 (2011/12/21)

Seven betaines were prepared by condensation of N,N'-diphenylamidines with malonic acid derivatives. The amidines were made via a multistep synthesis, starting from their corresponding fatty acids. Malonyl chloride and dipentachlorophenyl phenylmalonate, two derivatives of malonic acid, were obtained from malonic acid and benzyl chloride, respectively. Most of the products were characterized by IR, UV, 1H and 13C NMR. Biological assays of the synthesized betaines revealed their good antibacterial and antifungal activities against the Pseudomonas aeruginosa, Bacillus subtilis and Mucor ramannianus and an activity against Candida albicans.

MIXTURES OF MESOIONIC PESTICIDES

-

Page/Page column 29-30, (2011/02/24)

Disclosed are compositions comprising (a) at least one compound selected from compounds of Formula (1), N-oxides, and salt thereof, wherein R1 is phenyl optionally substituted with up to 5 substituents independently selected from R3,

ESTER DERIVATIVE AND MEDICINAL USE THEREOF

-

Page/Page column 79-80, (2010/11/08)

A therapeutic agent for hyperlipidemia which has no side effects on the liver unlike conventional MTP inhibitors and has excellent MTP inhibitory activity. Also, provided is an ester compound represented by the general formula (1): or a pharmaceutically a

ESTER COMPOUND AND MEDICINAL USE THEREOF

-

Page 98, (2008/06/13)

A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1") (wherein ???R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.; ???X is -COO- or -CON(R10)-; ???R3 and R4 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R5, R6 and R7 are each hydrogen atom, C1-C6 alkyl or C1-C6 alkoxy, etc.; ???R8 and R9 are each independently hydrogen atom, C1-C6 alkyl, -CON(R18)(R19) or -COO(R20), etc.; ???ring A, ring B and ring C are each independently aryl or heterocycle residue, etc.; ???Alk1 and Alk2 are each independently alkanediyl, etc.; ???l and m are each an integer of 0 or 1 to 3) or a prodrug thereof, or a pharmaceutically acceptable salt of either. The therapeutic agent selectively inhibits MTP in the small intestine, thus causes no such side effect as a fatty liver.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 37818-48-7